Aerie pharmaceuticals, inc. appoints david a. hollander as chief research & development officer, an executive officer, effective november 11, 2019

Aerie pharmaceuticals, inc. announced the appointment of david a. hollander, m.d., m.b.a., as chief research & development officer, an executive officer position reporting to vicente anido, jr., ph.d., the company’s chairman and chief executive officer. dr. hollander will commence his employment at the company on november 11, 2019 and will direct the company’s preclinical and clinical research and development groups, as well as medical and professional affairs. he was most recently chief medical officer, senior vice president at ora, inc.
AERI Ratings Summary
AERI Quant Ranking